Skip to main content

Botanikind settles in Basel

Botanikind
| News

Botanikind settles in Basel

14.09.2021

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for food and drink production.

Botanikind

Botanikind is pooling its European activities in its newly established headquarters in Basel. Botanikind AG was founded for this purpose will additionally coordinate global commercial activities and develop new innovations from its location in Basel. Botanikind was supported in settling by Basel Area Business & Innovation.

Botanikind has its operating headquarters in Shanghai and has established a vertically integrated supply chain in China. This means natural ingredients can be obtained directly from farmers for the food, drink and supplement industries. In doing so the company ensures quality and transparency between producers and consumers. The direct, simple supply chain additionally lowers costs. In China, the company sources from a broad range of natural raw materials and benefits from modern technologies.

Botanikind is proactively pursuing a decentralized structure in order to be as close to its customers as possible. The company sees Basel as the ideal location for its European headquarters as it is situated centrally and has great innovation potential due to the life sciences companies that are resident there. A team will now be established in Basel to make and implement strategic decisions for the European market. Furthermore, the company plans to open its own laboratory in Basel in the coming year. The proximity to life sciences companies is additionally important to Botanikind because the products it markets can also be used in supplements with health benefits.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.